This inventor holds 1 USPTO granted patent and 5 published patent applications and 2 EPO patents. Top assignees: Edigene Therapeutics (Beijing) Inc., Peking University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2023
Title: The Innovative Contributions of Zhongzheng Cao
Introduction
Zhongzheng Cao is a prominent inventor based in Beijing, China. He has made significant contributions to the field of RNA editing, showcasing his expertise through his innovative patent. His work has implications for various applications in biotechnology and medicine.
Latest Patents
Zhongzheng Cao holds a patent titled "Methods and compositions for editing RNAs." This patent provides methods for editing RNA by introducing a deaminase-recruiting RNA in a host cell for the deamination of an adenosine in a target RNA. The application further details deaminase-recruiting RNAs used in RNA editing methods and compositions comprising the same. He has 1 patent to his name.
Career Highlights
Throughout his career, Zhongzheng Cao has worked with notable organizations, including Edigene Therapeutics (Beijing) Inc. and Peking University. His experience in these institutions has allowed him to develop and refine his innovative ideas in RNA technology.
Collaborations
Zhongzheng Cao has collaborated with esteemed colleagues such as Pengfei Yuan and Yanxia Zhao. These partnerships have contributed to the advancement of his research and the successful development of his patent.
Conclusion
Zhongzheng Cao's work in RNA editing represents a significant advancement in biotechnology. His innovative methods and compositions have the potential to impact various fields, highlighting his role as a key inventor in this area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile